|
The
patent challenge
After becoming a signatory to the TRIPS agreement last year
and enactment of Patents (Amendment) Act in 2005, India has
become the flavour of the season. But India's patent infrastructure
is still in its infancy with inadequate manpower and an ill-equipped
patent office. There's a need for a quick action, discerns
Sapna Dogra
Upfront
Pfizer
agrees to sell its consumer healthcare business
Pfizer said that it has reached an agreement to sell its Pfizer
Consumer Healthcare (PCH) business to Johnson & Johnson
for $16.6 billion in cash, resulting in about $13.5 billion
in after-tax proceeds.
Acomplia
receives marketing authorisation in EU
Sanofi-Aventis announced that the European Commission has
granted marketing authorisation for Acomplia (rimonabant,
20 milligram per day) in all 25 European member states.
Alkem
ties up with Horphag Research
Alkem Laboratories has signed a contract with Geneva based
Horphag Research to source a high value nutraceutical ingredient,
Pycnogenol. Hector Bandelier, Director (Sales), Horphag Research
said, "Alkem Laboratories has already started using Pycnogenol
as an ingredient in their cardiovascular product Maxxio."
Parexel
International expands relationship with Synchron
Parexel International Corporation announced that it had entered
into a joint venture arrangement with Synchron Research Services.
Indoco
Remedies acquires API manufacturing facility
Indoco Remedies announced the acquisition of La NovaChem's
API manufacturing facility, located at Patalganga, Maharashtra.
Biotech
offers hope to drying drug pipelines
Over the last few decades, the area of biotechnology has evolved
as an important contributor to the pharmaceutical industry.
The Yes Bank report, 'Indian Biotechnology Industry—
fostering the knowledge revolution' reports on the status
of biotechnology industry in India.
|
